Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Atopic Dermatitis Clinical Trial
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
AGN-241751 in the Treatment of Major Depressive Disorder
Status: Enrolling, Phase II
Updated: 12/31/1969
Donald J. Garcia Jr., MD
mi
from
Austin, TX
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenfield, WI
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care-Southern Lakes VLCC
mi
from
Burlington, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Northshore Oncology Associates-Covington
mi
from
Covington, LA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
mi
from
Marshfield, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Loyola Center for Cancer Care and Research
mi
from
Orland Park, IL
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Epic Care Cyberknife Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Valley Regional Medical Center
mi
from
Brownsville, TX
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
West Valley Medical Center
mi
from
Caldwell, ID
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Medical City Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
West Houston Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Lake City Medical Center
mi
from
Lake City, FL
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Southern Hills Hospital - Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Gulf Coast Medical Center
mi
from
Panama City, FL
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Los Robles Regional Medical Center
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Urinary Tract Infection (UTI) Clinical Trial
The INSPIRE-ASP UTI Trial
Status: Enrolling
Updated: 12/31/1969
Clearlake Regional Medical Center
mi
from
Webster, TX
Click here to add this to my saved trials
Fragile X Syndrome (FXS) Clinical Trial
A Study of OV101 in Individuals With Fragile X Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Ovid Therapeutics Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Schizophrenia Clinical Trial
A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia
Status: Enrolling, Phase II
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Clayton Eye Clinical Research, LLC
mi
from
Morrow, GA
Click here to add this to my saved trials
Urinary Tract Infection Clinical Trial
Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwestern Medicine - Department of Obstetrics and Gynecology - Division of Female Pelvic Medicine and Reconstructive Surgery
mi
from
Chicago, IL
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Status: Enrolling
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana University School of Medicine - Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oral Mucositis Clinical Trial
A Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care NW
mi
from
Spokane, WA
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Norwalk, CA
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
San Juan,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Fundoplication Clinical Trial
Hernia Reduction Prior to Scheduled TIF Completion
Status: Enrolling
Updated: 12/31/1969
Northern Nevada Medical Center
mi
from
Sparks, NV
Click here to add this to my saved trials
Low Back Pain Clinical Trial
Optimization of Spinal Manipulative Therapy Protocols
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis Clinical Trial
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Edegem,
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Idiopathic Intracranial Hypertension Clinical Trial
Surgical Idiopathic Intracranial Hypertension Treatment Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
NeuroEyeOrbit Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Muscular Dystrophy, Duchenne Clinical Trial
Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital at Westmead
mi
from
Westmead,
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Stony Brook Cancer Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
A Safety Study of Growth Factor Use in Treatment With Brentuximab Vedotin Plus Chemotherapy
Status: Enrolling, Phase IV
Updated: 12/31/1969
Case Western Reserve University / University Hospitals Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Manassas, VA
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northfield, NJ
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Asthma Clinical Trial
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westminster, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fleming Island, FL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Garner, NC
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Michigan City, IN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Muncie, IN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Pomona, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
San Mateo, CA
Click here to add this to my saved trials